Your browser doesn't support javascript.
loading
Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial.
Raal, Frederick; Durst, Ronen; Bi, Ran; Talloczy, Zsolt; Maheux, Pierre; Lesogor, Anastasia; Kastelein, John J P.
Afiliação
  • Raal F; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.R.).
  • Durst R; Cardiology Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel (R.D.).
  • Bi R; Novartis Pharmaceuticals Corporation, East Hannover, NJ (R.B., Z.T.).
  • Talloczy Z; Novartis Pharmaceuticals Corporation, East Hannover, NJ (R.B., Z.T.).
  • Maheux P; Novartis Pharmaceuticals Corporation, Basel, Switzerland (P.M., A.L.).
  • Lesogor A; Novartis Pharmaceuticals Corporation, Basel, Switzerland (P.M., A.L.).
  • Kastelein JJP; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Netherlands (J.J.P.K.).
Circulation ; 149(5): 354-362, 2024 01 30.
Article em En | MEDLINE | ID: mdl-37850379

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Hipercolesterolemia Familiar Homozigota / Anticolesterolemiantes Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Hipercolesterolemia Familiar Homozigota / Anticolesterolemiantes Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article